BBI Solutions Acquires IBEX Technologies Inc.

Excelra Acquires BISC Global

April 19, 2023

Biotechnology

Excelra has acquired BISC Global, a consulting-led bioinformatics and data analytics services firm with offices in Europe and the US. The deal expands Excelra's AI/ML, bioinformatics and next-generation sequencing capabilities and combines complementary platforms and service offerings to accelerate drug discovery and development.

Veranex Acquires Fusion Biotec

December 13, 2022

Medical Devices

Veranex has acquired Fusion Biotec, a Southern California design and engineering firm specializing in complex electro-mechanical diagnostic instrumentation and medical devices. The acquisition brings Fusion's 15,000-square-foot facility and 45+ engineering staff into Veranex's Product Design & Engineering capabilities, expanding Veranex's diagnostic/IVD development, software/firmware reuse and Southern California footprint; financial terms were not disclosed.

Motion Solutions Acquires Ibex Engineering

August 3, 2022

Industrial Services

Motion Solutions (a portfolio company of Frontenac) announced that Ibex Engineering is now part of the Motion Solutions family. The acquisition brings Ibex’s precision linear and rotary positioning systems and custom OEM expertise to Motion Solutions, expanding its ultra-precision end-market access and automated manufacturing capabilities.

Novo Holdings Acquires BBI Group

June 15, 2021

Medical Devices

Novo Holdings A/S has agreed to acquire BBI Group from Exponent for an enterprise value of over GBP 400 million, becoming the company's majority shareholder. BBI, a Crumlin, South Wales–headquartered supplier of diagnostics reagents, lateral flow development and diagnostic manufacturing services with more than 400 employees, will benefit from Novo Holdings' life-sciences expertise to pursue organic and inorganic growth.

BBI Group Acquires DIARECT AG

June 3, 2020

Medical Devices

BBI Group has acquired DIARECT AG, a Freiburg-based supplier of recombinant autoimmune antigen products, integrating DIARECT's manufacturing facility to establish a centre of excellence for recombinant antigen development. The deal expands BBI's immunoassay reagent portfolio and capabilities, enabling the combined company to pursue high-growth disease segments and broaden DIARECT's geographic reach through BBI's larger sales organization.

Abenex Acquires Cisbio Bioassays from Argos Soditic

June 16, 2016

Biotechnology

French private equity firm Abenex has acquired Cisbio Bioassays from seller Argos Soditic. Abenex will partner with the biotech to support its organic and external growth strategy across pharmaceutical research and in vitro diagnostics; Cisbio has ~210 employees and generates over 85% of revenue outside France.